1-(1,3-benzodioxol-5-yl)-N-(trideuteriomethyl)butan-2-amine:hydrochloride

MBDB-d₃ (hydrochloride) is intended for use as an internal standard for the quantification of MBDB by GC- or LC-MS. MBDB is an analog of methylenedioxymethamphetamine (MDMA), differing only by the substitution of an ethyl for methyl group at the α-carbon. Like MDMA, MBDB is an entactogen that potently inhibits monoamine uptake.^1,2 This product is intended for forensic and research purposes.

Labelled MBDB (M265085). MBDB ia an analog of MDMA (M303985). MBDB is the N-methylated derivative of BDB (B198900), a hallucinogenic Phenylethylamine derivative. BDB is more potent than MBDB. MBDB is a CNS stimulant.

1. Nichols, D.E., Brewster, W.K., Johnson, M.P., et al. Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA) J. Med. Chem. 33(2),703-710(1990).
2. Nagai, F., Nonaka, R., and Satoh Hisashi Kamimura, K. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain Eur. J. Pharmacol. 559(2-3),132-137(2007).